Essentra’s Promising Sales Growth and Margin Recovery Drive Buy Rating
I'm PortAI, I can summarize articles.
Jefferies analyst Andrew Douglas has maintained a Buy rating on Essentra (ESNT) stock, citing promising sales growth and potential margin recovery. The company's recent trading update revealed significant sales increases, especially in the EMEA region. Despite some challenges, Douglas is optimistic about Essentra's ability to recover its sales and EBITA margins, setting a price target of 150p. RBC Capital also supports this view with a Buy rating and a price target of 155p, reinforcing confidence in the company's strategic position in the EU manufacturing sector.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments